- Home
- Companies
- Ellume Limited
- Products
- QIAreach - COVID Antigen & Antibody ...
QIAreach - COVID Antigen & Antibody Tests for the Laboratory Market
In partnership with global diagnostics company QIAGEN®, Ellume has developed two rapid COVID-19 tests: the QIAreach™ SARS-CoV-2 Antigen Test**** for active infections and the QIAreach™ Anti-SARS-CoV-2 Total Test** for past infections. Both tests are now available in the U.S. The tests are run on the eHub platform, an easy-to-use and portable digital device that provides results in less than 15 minutes.
- Early positive results from 3 minutes
- Simple testing process
- Minimal training requirements
- Single patient visit
- Objective automated test result
- No device calibration or maintenance required
- No cold chain required
- No continuous power supply required
- No computer access required
In partnership with QIAGEN®, Ellume has accelerated the development of two rapid, reliable COVID-19 tests to support the global response to the coronavirus pandemic.
The QIAreach™Anti-SARS-CoV-2 Total Test, is a high-performance serological test which detects antibodies in people who have been exposed to SARS-CoV-2. The test received US FDA Emergency Use Authorization (EUA) in May 2021*.
The QIAreach™ Anti-SARS-CoV-2 Antigen Test detects SARS-CoV-2 antigens in people with active infections. The test received US FDA Emergency Use Authorization (EUA) in August 2021**.